Glycogen storage disease type II: identification of four novel missense mutations (D645N, G648S, R672W, R672Q) and two insertions/deletions in the acid alpha-glucosidase locus of patients of differing phenotype

Biochemical and Biophysical Research Communications
M HuieRochelle Hirschhorn

Abstract

Glycogen storage disease type II (GSDII), an autosomal recessive myopathic disorder, results from deficiency of lysosomal acid alpha-glucosidase. We searched for mutations in an evolutionarily conserved region in 54 patients of differing phenotype. Four novel mutations (D645N, G448S, R672W, and R672Q) and a previously described mutation (C647W) were identified in five patients and their deleterious effect on enzyme expression demonstrated in vitro. Two novel frame-shifting insertions/deletions (delta nt766-785/insC and +insG@nt2243) were identified in two patients with exon 14 mutations. The remaining three patients were either homozygous for their mutations (D645N/D645 and C647W/C647W) or carried a previously described leaky splice site mutation (IVS1-13T-->G). For all patients "in vivo" enzyme activity was consistent with clinical phenotype. Agreement of genotype with phenotype and in vitro versus in vivo enzyme was seen in three patients (two infantile patients carrying C647W/C647W and D645N/+insG@nt2243 and an adult patient heteroallelic for G648S/IVS1-13T-->G). Relative discordance was found in a juvenile patient homozygous for the non-expressing R672Q and an adult patient heterozygous for the minimally expressing R672W an...Continue Reading

Citations

Feb 28, 2008·European Journal of Human Genetics : EJHG·Marian A KroosArnold J J Reuser
Nov 22, 2002·DNA and Cell Biology·Frank MartiniukWilliam N Rom
Oct 3, 2003·Biochemical and Biophysical Research Communications·Sylvia L AndersonBerish Y Rubin
Oct 29, 2000·Neuromuscular Disorders : NMD·S TsujinoN Sakuragawa
Nov 10, 2006·Journal of the Neurological Sciences·Young-Eun ParkDae-Seong Kim
May 18, 2004·Neuromuscular Disorders : NMD·Marian A KroosRudolf Korinthenberg
Jan 18, 2012·The Biochemical Journal·Peter J RoachVincent S Tagliabracci
Jul 16, 2011·Molecular Genetics and Metabolism·Chih-Chao YangWuh-Liang Hwu
Feb 5, 2000·Neurologic Clinics·A A Amato
Feb 5, 2000·Neurologic Clinics·G D Vladutiu
Jul 6, 2001·Muscle & Nerve·S DiMauro, C Lamperti
Feb 1, 2018·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Lily WuMark A Tarnopolsky
Dec 16, 1998·Current Opinion in Neurology·S DiMauro, C Bruno
May 23, 2000·Journal of Pediatric Endocrinology & Metabolism : JPEM·O N Elpeleg
Jan 19, 2012·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Deeksha S BaliPriya S Kishnani
Apr 11, 2018·BMJ Paediatrics Open·Narcisse ElengaJean-François Benoist
Mar 21, 2021·Neuromuscular Disorders : NMD·Ratna Dua PuriPriya S Kishnani
Jun 6, 2003·Biochemical and Biophysical Research Communications·Sylvia L AndersonBerish Y Rubin
Dec 4, 2003·Pediatric Neurology·Judy R PipoKousaku Ohno

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.